Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment [Phase 1]

View source ↗

Summary

A phase 1 trial is evaluating the pharmacokinetics and safety of orally administered decitabine in combination with cedazuridine in cancer patients with hepatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Cedazuridine (Cedazuridine)
• Decitabine (Decitabine)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING